Avalo Therapeutics Stock Probability of Future Stock Price Finishing Over 27.46
Avalo Therapeutics' future price is the expected price of Avalo Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Avalo Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Please specify Avalo Therapeutics' target price for which you would like Avalo Therapeutics odds to be computed.
Avalo |
Avalo Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Avalo Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Avalo Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Avalo Therapeutics is not yet fully synchronised with the market data | |
| Avalo Therapeutics is way too risky over 90 days horizon | |
| Avalo Therapeutics has some characteristics of a very speculative penny stock | |
| Avalo Therapeutics appears to be risky and price may revert if volatility continues | |
| Avalo Therapeutics currently holds 537 K in liabilities with Debt to Equity (D/E) ratio of 5.62, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avalo Therapeutics has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Avalo Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.92 M. Net Loss for the year was (31.54 M) with loss before overhead, payroll, taxes, and interest of (7.94 M). | |
| Avalo Therapeutics currently holds about 11.25 M in cash with (30.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2. | |
| Avalo Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 65.0% of Avalo Therapeutics shares are held by institutions such as insurance companies |
Avalo Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Avalo Stock often depends not only on the future outlook of the current and potential Avalo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Avalo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 277.7 K | |
| Cash And Short Term Investments | 7.4 M |
Avalo Therapeutics Technical Analysis
Avalo Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Avalo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Avalo Therapeutics. In general, you should focus on analyzing Avalo Stock price patterns and their correlations with different microeconomic environments and drivers.
Avalo Therapeutics Predictive Forecast Models
Avalo Therapeutics' time-series forecasting models is one of many Avalo Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Avalo Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Avalo Therapeutics
Checking the ongoing alerts about Avalo Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Avalo Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Avalo Therapeutics is not yet fully synchronised with the market data | |
| Avalo Therapeutics is way too risky over 90 days horizon | |
| Avalo Therapeutics has some characteristics of a very speculative penny stock | |
| Avalo Therapeutics appears to be risky and price may revert if volatility continues | |
| Avalo Therapeutics currently holds 537 K in liabilities with Debt to Equity (D/E) ratio of 5.62, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avalo Therapeutics has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Avalo Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.92 M. Net Loss for the year was (31.54 M) with loss before overhead, payroll, taxes, and interest of (7.94 M). | |
| Avalo Therapeutics currently holds about 11.25 M in cash with (30.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2. | |
| Avalo Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 65.0% of Avalo Therapeutics shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Tools for Avalo Stock
When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |